Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125133
Filing Date
2024-11-12
Accepted
2024-11-12 14:22:22
Documents
101
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q asth-20240930.htm   iXBRL 10-Q 4392264
2 EX-10.3 asth-ex10_3.htm EX-10.3 48040
3 EX-31.1 asth-ex31_1.htm EX-31.1 16133
4 EX-31.2 asth-ex31_2.htm EX-31.2 15778
5 EX-32 asth-ex32.htm EX-32 11993
6 EX-99.1 asth-ex99_1.htm EX-99.1 74889
7 GRAPHIC img123525869_0.jpg GRAPHIC 35722
  Complete submission text file 0000950170-24-125133.txt   19431947

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asth-20240930.xsd EX-101.SCH 2040623
103 EXTRACTED XBRL INSTANCE DOCUMENT asth-20240930_htm.xml XML 4643520
Mailing Address 1668 S. GARFIELD AVENUE 2ND FLOOR ALHAMBRA CA 91801
Business Address 1668 S. GARFIELD AVENUE 2ND FLOOR ALHAMBRA CA 91801 (626) 282-0288
Astrana Health, Inc. (Filer) CIK: 0001083446 (see all company filings)

EIN.: 870042699 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37392 | Film No.: 241446911
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)